Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FEQCS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,166
Award facts
- Contract value 100% obligated
- $4,165.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $4,165.86 by the Defense Logistics Agency for Nexplanon 68 mg implants. The contract, awarded on August 21, 2025, with an ultimate completion date of September 12, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare systems. The Nexplanon implant delivery fulfills the DLA's ongoing need for contraceptive medical devices to support military healthcare operations. The company's established portfolio demonstrates consistent success in competing for pharmaceutical delivery orders from the Defense Logistics Agency, leveraging its woman-owned small business status and registered SAM.gov credentials since 2001 to secure contracts across diverse product categories ranging from oncology treatments to vaccines and specialty medications.
Quick answers
Who was awarded contract SPE2DB25FEQCS?
SPE2DB25FEQCS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FEQCS worth?
The government has obligated $4,166 on SPE2DB25FEQCS.
Is contract SPE2DB25FEQCS an order under another contract?
Yes. SPE2DB25FEQCS is a delivery order under SPE2DB24D9113, an indefinite delivery contract.
Was contract SPE2DB25FEQCS competed?
The extent of competition for SPE2DB25FEQCS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award